المؤلفون: Coopmans, Eva C, Schneiders, Joppe J, El-Sayed, Nour, Erler, Nicole S, Hofland, Leo J, van der Lely, Aart-Jan, Petrossians, Patrick, Potorac, Julia, Muhammad, Ammar, Neggers, Sebastian J C M M

المصدر: European Journal of Endocrinology, 182 (6), 595-605 (2020-06)

مصطلحات موضوعية: Delayed-Action Preparations, Hormones, IGF1 protein, human, Ligands, Receptors, Somatostatin, Human Growth Hormone, Somatostatin, Insulin-Like Growth Factor I, pasireotide, pegvisomant, Acromegaly/blood, Acromegaly/drug therapy, Acromegaly/etiology, Adenoma/blood, Adenoma/complications, Adenoma/drug therapy, Adult, Cohort Studies, Drug Therapy, Combination, Female, Growth Hormone-Secreting Pituitary Adenoma/blood, Growth Hormone-Secreting Pituitary Adenoma/complications, Growth Hormone-Secreting Pituitary Adenoma/drug therapy, Hormones/therapeutic use, Human Growth Hormone/analogs & derivatives, Human Growth Hormone/therapeutic use, Humans, Insulin-Like Growth Factor I/drug effects, Magnetic Resonance Imaging/methods, Male, Middle Aged, Receptors, Somatostatin/blood, Somatostatin/analogs & derivatives, Somatostatin/therapeutic use, Treatment Outcome, Tumor Burden, Acromegaly, Adenoma, Growth Hormone-Secreting Pituitary Adenoma, Magnetic Resonance Imaging, Endocrinology, Diabetes and Metabolism, Endocrinology, General Medicine, Human health sciences, Endocrinology, metabolism & nutrition, Sciences de la santé humaine, Endocrinologie, métabolisme & nutrition

Relation: https://eje.bioscientifica.com/view/journals/eje/182/6/EJE-19-0840.xml; urn:issn:0804-4643; urn:issn:1479-683X

URL الوصول: https://orbi.uliege.be/handle/2268/293285